Marieke G. Sturkenboom

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Treatment of paracetamol poisoning can be shortened

Treatment of paracetamol poisoning can be shortened

Journal: Nederlands tijdschrift voor geneeskunde

Published: November 19, 2025

One Piece in the Puzzle of Tuberculous Meningitis: Dexamethasone Pharmacokinetics.

One Piece in the Puzzle of Tuberculous Meningitis: Dexamethasone Pharmacokinetics.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 21, 2025

Treatment of Acute Paracetamol Overdose: A Comprehensive Overview.

Treatment of Acute Paracetamol Overdose: A Comprehensive Overview.

Journal: Therapeutic drug monitoring

Published: July 07, 2025

Paracetamol Half-Life Declines over Time After an Acute Overdose.

Paracetamol Half-Life Declines over Time After an Acute Overdose.

Journal: Therapeutic drug monitoring

Published: May 14, 2025

In vitro Study of the Effects of Acetylcysteine on the International Normalized Ratio Over Time.

In vitro Study of the Effects of Acetylcysteine on the International Normalized Ratio Over Time.

Journal: Therapeutic drug monitoring

Published: March 30, 2025

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

Journal: IJTLD open

Published: February 15, 2025

The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review.

The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: January 29, 2025

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: January 16, 2025

Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.

Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.

Journal: BMJ open

Published: July 25, 2024

Safety, Efficacy, and Pharmacokinetics of Daily Optimized Doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.

Safety, Efficacy, and Pharmacokinetics of Daily Optimized Doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 03, 2024

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'.

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: March 07, 2024

Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study.

Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study.

Journal: International journal of antimicrobial agents

Published: January 22, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026